Medicare Common Ownership Transparency Act of 2023

Summary

Medicare Common Ownership Transparency Act of 2023 This bill requires Medicare Advantage (MA) organizations and prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit to report certain information about affiliated health care providers.  Specifically, MA organizations must report to the Centers for Medicare & Medicaid Services health care providers that the organization owns or in which the organization has a controlling interest, as well as the amount of incentive payments made to those health care providers and to other types of providers. PDP sponsors must similarly report pharmacies that the sponsor or a pharmacy benefit manager (PBM) owns or in which the sponsor or PBM has a controlling interest.  The Medicare Payment Advisory Commission must report on the status of vertical integration between Medicare health care providers, pharmacies, PDP sponsors, MA organizations, and PBMs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 25 July 2023

   Introduced

   Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 25 July 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 25 July 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 28 July 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 17 December 2024

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 25 July 2023 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 25 July 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 25 July 2023

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 25 July 2023

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Murphy, Gregory F. [R-NC-3] · R · Sponsor
• · hswm00 · Standing
• · hsif00 · Standing

Related records

• related to → Health Care Price Transparency Act of 2023
• related to ← Lower Costs, More Transparency Act